World's Best Scientists 2026 revealed!
Anthony P. Adamis

Anthony P. Adamis

D-Index & Metrics

Medicine

D-Index
94
Citations
46338
World Ranking
10283
National Ranking
5287

Anthony P. Adamis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anthony P. Adamis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 210 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anthony P. Adamis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony P. Adamis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2019 - Member of the National Academy of Medicine (NAM)

Overview

Anthony P. Adamis is affiliated with Genentech in the United States and is primarily engaged in medical research focused on ophthalmology. Their work spans several subfields including ophthalmology and radiology, nuclear medicine, and imaging. The primary area of study involves retinal diseases and treatments, with related attention to retinal imaging and analysis, glaucoma and retinal disorders, retinopathy of prematurity studies, retinal and macular surgery, and other retinal and optic conditions.

Recent publications reflect their engagement in advancing knowledge on retinal disorders and therapeutic approaches. Notable papers include:

  • "Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration" (2021, Ophthalmology)
  • "Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade" (2020, Eye)
  • "Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease" (2024, Ophthalmology Science)
  • "Contents" (2022, Ophthalmology)
  • "Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection" (2024, PLoS ONE)

Anthony P. Adamis has collaborated frequently with several researchers in the field. Frequent co-authors include:

  • Christopher Brittain
  • Peter A. Campochiaro
  • Margaret Chang
  • Daniel M. Miller
  • Dante J. Pieramici

Their work is published primarily in the following venues:

  • Ophthalmology
  • Eye
  • Ophthalmology Science
  • PLoS ONE

Anthony P. Adamis has produced research predominantly in the field of medicine with a strong focus on retinal diseases and related imaging techniques. These areas are reflected in the main topics of their research:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Glaucoma and retinal disorders
  • Retinal and Optic Conditions
  • Retinopathy of Prematurity Studies
  • Retinal and Macular Surgery

They have received recognition as a member of the National Academy of Medicine since 2019.

Best Publications

  • Pegaptanib for neovascular age-related macular degeneration

    E.S. . Gragoudas;A.P. Adamis;E.T. Cunningham;M. Feinsod

  • Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

    Eugene W. M. Ng;David T. Shima;Perry Calias;Emmett T. Cunningham

  • Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

    Anthony P. Adamis;Anthony P. Adamis;Joan W. Miller;Maria-Teresa Bernal;Donald J. D'Amico

  • A central role for inflammation in the pathogenesis of diabetic retinopathy

    Antonia M. Joussen;Vassiliki Poulaki;Minh Ly Le;Kan Koizumi

  • Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.

    Jayakrishna Ambati;Jayakrishna Ambati;Balamurali K Ambati;Balamurali K Ambati;Sonia H Yoo;Sonia H Yoo;Sean Ianchulev

  • Ten years of anti-vascular endothelial growth factor therapy

    Napoleone Ferrara;Anthony P. Adamis

  • Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

    David M. Brown;Quan Dong Nguyen;Dennis M. Marcus;David S. Boyer

  • Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

    Kazuaki Miyamoto;Samer Khosrof;Sven-Erik Bursell;Richard Rohan

  • Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

    Joan W. Miller;Anthony P. Adamis;David T. Shima;Patricia A. D'Amore

  • Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

    Kazuaki Nishijima;Yin-Shan Ng;Lichun Zhong;John Bradley

  • A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.

    Emmett T Cunningham;Anthony P Adamis;Michael Altaweel;Lloyd P Aiello

  • Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

    Anthony P. Adamis;David T. Shima;Michael J. Tolentino;Evangelos S. Gragoudas

  • Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

    Magdalena G. Krzystolik;Mehran A. Afshari;Anthony P. Adamis;Jacques Gaudreault

  • Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina

    Antonia M. Joussen;Toshinori Murata;Toshinori Murata;Akitaka Tsujikawa;Akitaka Tsujikawa;Bernd Kirchhof

  • Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.

    Antonia M. Joussen;Vassiliki Poulaki;Nicholas Mitsiades;Bernd Kirchhof

  • VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    E S Gragoudas;A P Adamis;E T Cunningham;M Feinsod

  • VEGF-initiated blood-retinal barrier breakdown in early diabetes.

    Tamim Qaum;Qingwen Xu;Antonia M. Joussen;Mark W. Clemens

  • INTRAVITREOUS INJECTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCE RETINAL ISCHEMIA AND MICROANGIOPATHY IN AN ADULT PRIMATE

    Michael J. Tolentino;Michael J. Tolentino;Joan W. Miller;Evangelos S. Gragoudas;Frederick A. Jakobiec

  • Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

    David M. Brown;Peter A. Campochiaro;Robert B. Bhisitkul;Allen C. Ho

  • Ocular neovascularization: an epidemiologic review.

    Patricia Lee;Cindy C. Wang;Anthony P. Adamis

Frequent Co-Authors

Joan W. Miller
Joan W. Miller Massachusetts Eye and Ear Infirmary
Evangelos S. Gragoudas
Evangelos S. Gragoudas Massachusetts Eye and Ear Infirmary
Shiro Amano
Shiro Amano University of Tokyo
Patricia A. D'Amore
Patricia A. D'Amore Massachusetts Eye and Ear Infirmary
Judah Folkman
Judah Folkman Boston Children's Hospital
Lloyd Paul Aiello
Lloyd Paul Aiello Harvard University
Napoleone Ferrara
Napoleone Ferrara University of California, San Diego
Nicholas Mitsiades
Nicholas Mitsiades Baylor College of Medicine
Iain L. Campbell
Iain L. Campbell University of Sydney
George D. Yancopoulos
George D. Yancopoulos Regeneron (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare careers doesn’t always require the traditional medical school route. There are many paths available to fit different interests and educational backgrounds. For example, those seeking entry into the rapidly growing healthcare sector can consider medical billing and coding financial aid options for online programs, helping to lower the barrier to entry in administrative roles.

Prospective nurses are often concerned about admission tests, but you might wonder, do you have to take the teas test to get into nursing school? Some nursing schools offer alternative pathways that do not require TEAS or HESI exams, making it easier to start your nursing journey.

For those interested in leadership roles, a healthcare administration associate degree online can open the door to management positions in hospitals, clinics, and other medical facilities.

Already a registered nurse? Fast-track your career growth with rn to fnp programs, bridging the gap between an associate degree and a master's level Family Nurse Practitioner qualification.

Best Scientists Citing Anthony P. Adamis

Trending Scientists

Recently Published Articles